Nostrums, quackery, and ethics in vascular surgery: how to remain true to the path of Hippocrates and still feed our families  by Ascher, Enrico
PRESIDENTIAL ADDRESS
From the Eastern Vascular Society
Nostrums, quackery, and ethics in vascular
surgery: How to remain true to the path of
Hippocrates and still feed our families
Enrico Ascher, MD, Brooklyn, NYI would like to start by thanking you for the opportu-
nity to have served this society in many capacities and, now,
as your President. I am truly honored and humbled by the
experience of working for the Eastern Vascular Society
(EVS) in this high capacity and in these times of challenge
for our specialty. The presidency of our nation’s youngest
yet largest regional vascular society has been one of the
proudest achievements of my professional career. Here, I
have developed many sincere and durable friendships. I
have learned immensely from my predecessors, as well as
from the future leadership, and I have witnessed the true
commitment of an executive council that has been relent-
less in pursuing the highest standards for our regional
society.
As the complexity of our specialty evolves and the
challenges become more sophisticated, I anticipate an even
larger role for the EVS—beyond the scientific environ-
ment. We must band together as the largest regional group
in this country to study and develop strategies that can help
our members to fend off unfair competition. We should
continue to explore methods of communicating the con-
cept of a vascular specialist to our medical colleagues and to
the lay public, and we are obliged to protect and defend
ourselves from fraudulent expert witness testimony. No
longer can we afford to concentrate solely on the most
current and exciting scientific data. Issues including reim-
bursement, ethics, and recognition of vascular surgery as a
mature and independent specialty should be addressed.
These issues are crucial on both the national and regional
levels. The world is changing and so must we. This Society
has been proactive in developing programs focusing on the
major areas that affect our daily clinical practices, and I call
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doi:10.1016/j.jvs.2004.05.008for all members to join in the effort. Complacency will only
help those who are competing for our patients and will not
thwart those who hinder the natural evolution of our
continued success as vascular specialists.
Last year, in my presidential address to the Society for
Clinical Vascular Surgery, I chose to define the vascular
surgeon as a vascular specialist.1 The intended role of a
vascular specialist would be to provide total vascular care to
patients presenting with vascular diseases as well as to
actively participate in directing noninvasive vascular diag-
nostic laboratories. Also, for the first time ever, I called for
a shortened 5-year training paradigm for vascular surgery to
make vascular surgery residency more focused, effective,
and attractive to potential candidates. Today, I choose to
share with you my thoughts about ethics in vascular surgery
and to call your attention to changes in the business of
vascular surgery.
Before I relate my thoughts on these subjects, allow me
to take a moment to recognize a surgeon who has provided
me with the necessary tools to build a productive career in
vascular surgery. Indeed, vascular surgeons worldwide have
benefited from the talent, creativity, and leadership of
Frank J. Veith. Over the years, he has courageously and
successfully tackled the most politically charged topics af-
fecting vascular surgery. Frank is a brilliant strategist who
tirelessly follows his goals and beliefs. Some of these have
been to integrate endovascular treatment into the arma-
mentarium of the vascular surgeon and to achieve vascular
surgery board independence. His commitment to our spe-
cialty is inspiring, and I feel privileged to be a friend of this
pioneer in vascular surgery. I would also like to recognize
the influential role that Dr Robert Hobson has played in my
career as a vascular surgeon. Although he was not directly
involved in my surgical training, he has been a role model
for me and for an entire generation of vascular surgeons.
Bob is a true surgeon-scientist who has written many
landmark clinical and basic science papers. He has accom-
plished greatly at the helm of every important vascular
society in this country, and his friendly and welcoming
demeanor is an asset to emulate as we try to attract the best389
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dents to join vascular surgery.
This is a rare public moment when one has the pleasure
to show his appreciation to his or her family. To Katia, my
lovely wife and companion of 28 years, I recognize your
undivided attention, care, and support that have enabled
me to realize many of my academic dreams as well as to
fulfill an often absurd schedule. A respected physician in her
own right, Katia is an accomplished nephrologist at the
Albert Einstein College of Medicine who is an example of
what a physician should be—that is, knowledgeable, dedi-
cated, committed, and compassionate. To my children,
Michael and Andrea, I wish to say that I love you and I am
very proud of you. I would also like to recognize my
mother, Emilia, and my late father, Samuel, for their guid-
ance and support throughout my life.
Today, I stand here before you as a fellow surgeon who
is concerned about the very survival of our specialty, and I
will impart to you my thoughts on how we must become
proactive in the defense of our livelihood while maintaining
acceptable codes of ethics. Ever since the modern evolution
of our specialty as vascular surgeons, interventionists, and
clinicians, we have been under a constant assault that
continues to threaten our existence. I truly believe that we
must stand together as a whole and compete with those
who would falsely usurp that which we have thus far
achieved, as we continue to remain faithful to ethical prin-
ciples outlined for us by Hippocrates, Galen of Pergamum,
and Moses Maimonides.
NOSTRUMS AND QUACKERY
It is easy for all of us to visualize the status of medicine
as it was practiced in early US history. Doctors, both real
and phony, peddled their miracle potions at carnival side-
shows and on the road in their caravan wagons alongside
the common peddlers of pots and pans. The problem was
so rampant that the US Postmaster General was given
authority in 1872 to forbid the use of the mail by “persons
operating fraudulent schemes” in the initial effort to con-
front the unscrupulous purveyors of deception.2 Thus was
constituted the first federal power to regulate misleading
advertising. Still, the “quacks” persisted in the fleecing of
the gullible. The word quackery derives from the word
quacksalve: “someone who boasts about his salves.” The
modern-day definition of a quack is “a pretender to medical
or other skill.” The Federal Drug Administration defines
quackery as “the promotion for profit, of a medical remedy
known to be false or unproven.”3
Similarly, a nostrum is a medicine whose effectiveness is
unproven and whose ingredients are usually secret—a pop-
ular but untested remedy for problems or evils. Even today,
society is not free of nostrums. Chelation therapy, an
unproven form of treatment for occlusive arterial disease, is
still being widely used in this country.
At the time, the culture of medical chicanery was so well
integrated into American society that Mark Twain would
introduce one of his most beloved characters, Colonel
Beriah Sellers, who first appeared in Twain’s 1873 novelThe Gilded Age.4 Colonel Sellers is portrayed as a visionary
who is convinced that his odd inventions will bring him
fame and riches. One of his many schemes involves the
marketing of the “Infallible, Imperial, Oriental Optical
Liniment, and Salvation for Sore Eyes—the Medical Won-
der of the Age! Small Bottles Fifty Cents, Large Ones a
dollar!” Of course, this is just Colonel Seller’s attempt to
take care of his family. After all, as he explains, one could
not feed his family on expectations.
In the early 20th century it was still common practice to
hawk cure-all potions and devices to rid all ailments and
illnesses. However, it was the proliferation of dangerous
electroconvulsive devices that moved the American Medi-
cal Association (AMA) to become involved in the regula-
tion of medicines and devices. In 1905, the AMA estab-
lished its Council on Pharmacy and Chemistry to decide
which products were allowed to advertise in its official
publications. One year later, the AMA created a Propa-
ganda Department to collect and disseminate information
about health quackery. In 1911, the first volume of Nos-
trums and Quackery, a compilation of health frauds of the
day was published under the auspices of the AMA.5 These
frauds were so pervasive that they would require 9 extensive
annual editions of unique articles to expose just the most
well-known adventures.
At that time, the AMA enacted a ban on advertising by
physicians. This resulted in the AMA gaining further con-
trol of the medical profession in the United States that
would have the effect of silencing competition to its mem-
bership. Control of the medical marketplace by the AMA
was unchallenged until 1975, when the United States
Federal Trade Commission (FTC) levied an antitrust suit
against the American Medical Association.6 The FTC
charged that the ban on physician advertising discouraged
competition and unfairly disadvantaged consumers. After
years of legal battling, the FTC won the suit, and in 1982
the AMA ban on physician advertising was lifted. This has
led to the subsequent return of the peddling of “snake oil”
by some entrepreneurs that continues to this day. Decep-
tive euphemisms, phony authorships, biased educational
seminars, paid celebrity endorsements, coupons, and
“stampede” marketing tactics are just some of the numer-
ous and questionable tactics that are employed today and
are meticulously designed to corral consumers. Others have
initiated sophisticated and coordinated campaigns de-
signed to acquire a patient population that has traditionally,
and rightfully, been the domain of vascular surgery.
CODES OF ETHICS
Whether we like it or not, the practice of medicine
today is as much a business as it is a science practiced with
art. For obvious reasons, it cannot be professed as philan-
thropy or be based solely on the Good Samaritan spirit. Not
to recognize this reality is naive and tantamount to profes-
sional failure. If we are to embark together on the trek to
professional survival, we must examine the basic philo-
sophic principles that have guided the art of the practice of
medicine for 2 and a half millennia.7 The oath of Hip-
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of medicine. It has been sworn to by most physicians in
modern history and is considered to be the foundation
upon which medical ethics are built. Adopted by Hip-
pocrates’ followers in the School of Cos more than 2,500
years ago, it appears on its face that the emphasis of this
pledge is primarily directed at establishing a self-propagat-
ing secret society. Interestingly, Hippocrates specifically
forbade the practice of surgery by physicians. Let me read
excerpts from the Hippocratic Oath:
To hold him who has taught me this art as equal to my
parents and to live my life in partnership with him, and if
he is in need of money to give him a share of mine, and to
regard his offspring as equal to my brothers in male
lineage and to teach them this art—if they desire to learn
it—without fee and covenant; to give a share of precepts
and oral instruction and all the other learning to my sons
and to the sons of him who has instructed me and to
pupils who have signed the covenant and have taken an
oath according to the medical law, but no one else. I will
not use the knife, not even on sufferers from stone, but
will withdraw in favor of such men as are engaged in this
work.7
These were the first historically recorded guidelines for the
ethical practice of medicine.
Galen, the revered physiologist, anatomist and surgeon
of the second century AD, appears to have been the first to
address the issue of compensation and dictated that money
was not to be an instrument that defined a physician’s
principles. He wrote: “The physician should be contemp-
tuous of money, interested in his work, self controlled, and
just. Once he is possessed of these basic virtues, he will have
all others at his command.”7 Galen was eclectic in his
theories and believed that the best doctor is also a philoso-
pher. This was certainly feasible in the aristocracy of Galen’s
time but not a viable option for today.
In the 12th century the great philosopher and physician
Moses Maimonides also rejected the idea of monetary
reward. The following is an excerpt from his prayer: “Let
not desire for wealth or benefit blind me from seeing the
truth. Deem me worthy of seeing in the sufferer who seeks
my advice a person neither rich nor poor. Friend or foe,
good man or bad; of a man in distress, show me only the
man. If doctors wiser than me seek to help me understand,
grant me the desire to learn from them, for the knowledge
of healing is boundless.”8
These ancient codes have served physicians and patients
well. However, we must now embrace a model of medical
ethics that reflects today’s socioeconomic climate. We can-
not allow the loose interpretation of these prayers by poli-
ticians and administrators whose intent is to subjugate
physicians to accept diminishing reimbursement. Nor can
we afford to practice a model more suited to the priesthood
than to health care providers. Interestingly, the specialty of
vascular surgery is one of few that have not yet published a
comprehensive code of ethics. Hopefully, this will soon beaccomplished by the Society for Vascular Surgery (SVS).
Currently, the SVS is developing a code of ethics for its
membership that is intended to serve as guidelines in med-
ical, ethical, social, and professional relationships in the
practice of vascular surgery. This code represents the stan-
dards used to evaluate a member’s maintenance of good
professional standing and to evaluate qualifications for
membership by applicants. To my knowledge, there will be
9 distinct areas of focus for addressing ethical issues of
importance to every vascular surgeon: (1) vascular care
provider; (2) health care providers; (3) patient and patient’s
family; (4) legal profession; (5) government; (6) insurance,
compensation, and reimbursement agencies; (7) industry;
(8) patients and research; and (9) community and world
affairs.
For each of these distinct areas, there are guidelines for
identifying issues and their paths of resolution. They are not
earth-shattering revelations, but rather common-sense re-
alities. When these guidelines are finalized, I propose that
they be adopted by the EVS as well as by the other regional
and national vascular societies. We need to speak with one
voice so there are no misunderstandings among vascular
surgeons.
In the meanwhile, I now lightheartedly offer to you my
vision of a modern Ten Commandments for vascular sur-
geons that I believe can help us to define our purpose in the
21st century:
1. Respect your patients.
2. Do your patients no harm.
3. Do not misrepresent your abilities.
4. Do not bear false witness against your colleague.
5. Do not covet your colleague’s practice.
6. Do not steal your colleague’s patients.
7. Honor your mentors.
8. Mentor your juniors.
9. Share your knowledge with your peers.
10. Advance the ideals of vascular surgery.
I am pleased to inform you that your Council has voted
favorably on my proposal to create an Ethics Committee to
be chaired by Drs Keith D. Calligaro and Clement Darling,
III. This ethics committee will evaluate meritorious com-
plaints by members of any unfair, unethical, or unsafe
practices by any institution or physician. An example of
such a charge is a member who believes he or she has been
affected by mail sent by other vascular specialists to their
referring physicians claiming unsubstantiated superior re-
sults in their clinical practices. This overdue service from
the society will go a long way to curb increasingly frequent
abuses of “practice bashing.” All charges received by the
Society will undergo review by the ethics committee. The
defendant will then be afforded due process to address any
allegation in writing. EVS members found to be not com-
pliant with the Society’s published ethical standards may be
either censored or suspended for a specified period of time.
Additionally, the EVS will pursue an affiliation with the SVS
to extend their expert witness testimony program to in-
clude cases referred by EVS members.
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Vascular surgery has always been one of the minorities
in the world arena of surgical specialties. Even though we
have developed the techniques and standards of care for
peripheral vascular disease, we are now on the brink of
losing our status as the leaders in the prevention and manage-
ment of vascular diseases. Today, I wonder how we came to
this situation and what we can do to maintain our prominence
in the care of peripheral vascular disease. Naturally, we desire
to establish a legacy that will assure the welfare of our patients,
facilitate our prosperity, and guarantee professional stability
for the upcoming generation of vascular surgeons.
Is the issue of our identity important? I believe so.
Without a doubt we have been under a sustained assault by
radiologists and cardiologists, and it is time to defend
ourselves. On a daily basis, our patients hear advertisements
on the radio, see portrayals in television shows, and read in
newspapers and magazines of the association of cardiolo-
gists and interventional radiologists in the care of peripheral
arterial disease. Rarely are vascular surgeons mentioned.
How confident can our patients be when they are seeing the
mysterious and little known entity, the vascular surgeon,
and everyone else is proudly under the care of a cardiologist
for their carotid disease? We have always been, and cur-
rently remain, an unknown and misunderstood consumer
commodity. Interventional cardiologists are taking advan-
tage of our little known status to move forward, aiming to
take the lead in endovascular techniques and portray us as
surgeons who are resistant to natural evolution. Consider
this month’s Concepts in Contemporary Cardiology con-
ference in Houston and an ominously titled presentation,
“Distal Protection and Low Profile Stent Delivery Devices
Have Rendered Surgical Carotid Endarterectomy Extinct.”
There are many obvious reasons why we remain largely
unknown. One of these is that we are not recognized as an
independent specialty from general surgery. However,
there is hope in the horizon. The Councils of the EVS and
the SVS, as well as the membership of the Association of
Program Directors in Vascular Surgery have voted to sup-
port the continued efforts by the American Board of Vas-
cular Surgery to achieve an American Board of Medical
Specialties (ABMS)–approved independent board status.
As you may know, the American Board of Surgery (ABS)
has put forward an application to the ABMS for a Primary
Certificate in Vascular Surgery; that is, vascular surgeons no
longer need to pass general surgery boards before being
certified in vascular surgery. This application received unan-
imous endorsement by the members of the ABS who
recognized vascular surgery as a specialty and not subspe-
cialty. Clearly, this is a stepping stone to complete board
independence in vascular surgery.
VASCULAR SURGERY IN THE MEDIA—HOW
ARE WE PRESENTED?
Until recently, the most significant public presentation
of a vascular surgeon in the media may have been in the
1993 movie The Fugitive. Dr Kimble, a vascular surgeon,becomes suspicious that tissue samples from trial patients
that he submitted for pathology were switched, and his
friend, Dr Nichols, a cardiologist who was the primary
investigator for the anti-plaque drug Provasic, orders his
murder to prevent him from discovering the improprieties.
However, Dr Kimball was not home when the killer struck,
resulting in the murder of his wife, for which he was falsely
convicted. At the end of the story, Dr Nichols is confronted
as he delivers his keynote address to the Annual Meeting of
the International Association of Cardiology and Dr Kim-
ball, the vascular surgeon, is proven to be the good guy.
After a decade of media anonymity, vascular surgeons
have now once again been presented to the lay public. On
November 20, 2003, an episode of the TV show ER
depicted a medical transport helicopter crash. One of the
central themes of this episode is the failure of vascular
surgery to respond to numerous calls for emergency con-
sultation for a patient who sustains carotid trauma. Finally,
an emergency department resident places a carotid stent
under fluoroscopy and saves the patient’s life. References to
the absent vascular surgeon were repetitive and unfavor-
able. This episode was seen in over 25 million homes in the
United States—and many more worldwide.9 This awesome
negative publicity for our specialty will only increase and be
reiterated in syndicated and rerun episodes. Improved com-
munications with the media can only help to avert these
potentially damaging situations.
MARKETING IN VASCULAR SURGERY
America has always been progressive, innovative, and
possessed of frontier spirit, including its approach to med-
icine. While we, as vascular surgeons, must do much more
to ensure our survival, we must not do so at the expense of
our ethics or our honor, or to our charge to our patients.
The total US health and medical advertising spending
reached nearly $11 billion by the end of 2003. This has
resulted in meticulously synchronized campaigns to pro-
mote drugs, devices, and procedures. Recently, the Inter-
net has been an exponentially growing means by which
physicians have been able to promote their practices, edu-
cate their patients, and communicate with other profession-
als. The amount of online advertising expenditures on
health-related Web sites in 1999 was $200 million. This
figure was near $350 million in 2003 and is predicted to be
as much as $700 million in 2004. The once traditional
media such as newsletters and advertising in newspapers
and consumer magazines are no longer the only means.
Internet-driven health informatics can be spontaneously
distributed, without the lengthy preparation needed to
disseminate a newsletter or magazine.
Today’s consumers actively participate in their care,
more confident and inquisitive than those of just a few short
years ago. Especially important for vascular surgeons, el-
derly patients are the fastest growing base of online health
consumers. The electronic information age is no longer
novel or limited to the young.
We must vigorously publicize ourselves to the public
and health care providers as the premiere body of expertise
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that all national and regional vascular societies should join
together in this effort. Therefore, I am calling for the
establishment of a blue-ribbon panel that will define our
common marketing goals and make recommendations as to
how we may most effectively exploit these goals to their
maximum potential. We must get out the message as loudly
as we can afford it. The American Vascular Association has
created effective marketing campaigns that have signifi-
cantly contributed to increased awareness of the role of
vascular surgery in the prevention and treatment of vascular
diseases. Under the leadership of Bill Flinn, our current
Recorder, this association has blossomed and its national
screening program for aortic aneurysms, carotid disease,
and lower extremity occlusive disease has been a tremen-
dous success. In my opinion, it is appropriate to develop
public awareness programs related to vascular diseases by
medical societies, hospitals, or individual physicians. It is
inappropriate, however, to use this information as part of a
scheme to divert patients away from physicians who are
delivering equally good care. Increasingly, some major
universities do advertise their physicians as the “best in the
region” without proof. This practice should be discouraged
since it is unfair and it may have a negative impact on their
physicians’ reputations.
Careful consideration should be exercised to avoid
returning to the era of nostrums and quackery—perceived
or real. Kaiser Permanente, for example, invests
$60,000,000 annually for advertisement, and it gained
nearly 500,000 new members in 1999 alone. In that same
year, they were sued for fraud over mass market advertise-
ment stating that their physicians had total patient medical
management control.10 Because we have an obligation to
share our medical expertise with other professionals, we
may not claim that we have sole ownership of a procedure.
However, factually supported claims regarding our total
commitment to the prevention, diagnosis, and treatment of
vascular diseases are acceptable. It is naive to assume that
these goals can be achieved without the support of consult-
ants in marketing and advertising; these experts will make
recommendations for political and business strategies and
act as our principals in the conduct of our campaign.
THE BUSINESS OF VASCULAR SURGERY
Let us address the business of vascular surgery. As you
know, the United States is the number 1 nation in the world in
terms of health care spending. On a per capita basis, health
Table I. AMGA compensation and productivity survey, 20
Specialty
Y
2002 2001
Radiology: interventional 401,000 356,000
Cardiac / thoracic surgery 400,500 401,440
Cardiology: cath lab 329,494 310,500
General surgery 269,122 255,304spending in the United States is 50% higher than in the next
highest nation. Our health care costs constitute 14.9% of
our gross domestic product and these costs are expected to
rise to 18.4% within the next decade. Unfortunately, nearly
one third of the $1.6 trillion we now spend on health care
goes to care that is repetitive, or at a minimum, fails to
improve patient health. Hospital costs are rising as well;
fully 25% of all health care dollars are dedicated to admin-
istration. In 1999, that meant $300 billion went to pay for
administrative bureaucracy.11 A substantial portion of this
hospital bureaucracy is already being performed by you, the
vascular surgeon, without fair compensation for your time
and effort. It is time to challenge our administrators for
adequate reimbursement for our work. For example, if you
are responsible for the running of the hospital’s vascular
laboratory, you should receive appropriate monetary com-
pensation beyond the professional component. There are
many similar programs where surgeons routinely perform
uncompensated labor. Some full-time vascular surgeons are
taxed and taxed again for the privilege of working in an
academic institution. We need to be more determined when
negotiating new contracts with the hospital administration.
We are a very profitable group of surgeons for the hospital,
but we often underestimate our influence and value.
These are difficult times for vascular surgeons trying to
establish, maintain, and grow their practices. Various fac-
tors, including rising malpractice premiums, increasing staff
salaries and benefits, and federal regulations all seem to be
at work against the business of medicine. Rather than
getting discouraged, we should think about strategies to
minimize this burden and maximize our productivity. Why
not enlist the help of our organization, the EVS, to start
looking into these issues? Many of these issues are prevalent
enough that it should not be difficult to generate interest
among our members. In the meantime, one should ques-
tion everything related to his or her practice. Create a
vascular center where other vascular services can be pro-
vided with the intent of providing total vascular care.
Develop a plan to attract new patients and do not hesitate
to devote up to 5% of your practice’s total revenue to
marketing. Retain efficiency consultants who specialize in
health care and who can recommend ways to improve
workflow, decrease costs, and increase revenue.
A basic truth is that the practice of medicine is a
high-volume, low-profit business. We can no longer de-
pend on surgical cases to be our major source of reve-
nue—we need to look for other sources of income. For
eport12
1999–2002
2000 1999 % Change $ Change
306,000 300,000 33.67 101,000
389,926 389,474 2.83 11,026
286,000 279,710 17.80 44,543
244,794 243,362 10.59 25,76003 r
ear
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Institute of New York was directly attributable to vascular
operations and endovascular procedures.
Interventional radiologists are reported as the most
highly paid physicians, having the highest median compen-
sation in 2002 at $401,000.12 Interventional radiologists
also received the highest percentage salary increase among
specialties, at 33.7% from 1999 to 2002. Cardiac surgeons
earned only a 2.8% increase. Interventional radiologists also
received the highest percentage salary increase, with a
12.64% increase from $356,000 to $401,000 (Table I).
A separate study showed that vascular surgeons with
more than 3 years experience earned a net income of
$329,000, including base salaries, net income, or hospital
guarantees minus expenses.13 This is the second lowest rate
of compensation—just above the rate paid to general sur-
geons (Table II). The Stanford University School of Med-
icine places median salaries for vascular surgeons even low-
er—just $256,000 (1999-2000).
What is the value of expertise in vascular surgery? A
below-average salary is hardly satisfactory. How can we
attract and maintain talent with compensation that is close
to last amongst comparable specialties? The business of
vascular surgery is faltering. Most vascular surgeons are not
businessmen to begin with. Therefore, as in all businesses,
we must “meet the bottom line”—something that we have
failed to fully address.
Before I make my closing remarks, please allow me a
moment to thank those who are the pillars of my service at
Maimonides Medical Center. I would like to thank Anil
Hingorani, MD, my partner and friend, who continues to
amaze me with his clinical and academic production; Wil-
liam Yorkovich, RPA, our research coordinator, for his hard
work and unwavering commitment to the service over the
past 12 years; Eleanor Iadgarova, RN, for her enormous
dedication to our clinical practice; Natalia Markevich, MD,
RVT, whose skills and enthusiasm for vascular ultrasound is
moving us to the next level; Theresa Jacob, PhD, for her
basic science contributions to our program; Richard
Schutzer, MD, for his enthusiasm and endovascular skills;
Sergio Salles-Cunha, PhD, for helping me build one of the
largest and most reliable vascular laboratories in this coun-
try; and, last but not least, Anne Ober, our assistant admin-
istrator who works with her heart and does everything well.
CONCLUSION
Consumers are now being educated by other special-
Table II. Net compensation for physicians with more
than 3 years experience12
Specialty Compensation
Surgery: cardiovascular $515,000
Cardiology: interventional $468,000
Surgery: vascular $329,000
Surgery: general $291,000ties. They are enlightening themselves in the importantmatters affecting every aspect of their health care—includ-
ing disease processes, treatment options, payor reimburse-
ments, and provider selection. What they are learning now
may well be impossible to unlearn. The time to act is now,
before the opportunity to define ourselves becomes forever
lost to us. We need to identify ourselves not only to patients
and health care providers, but also to those who will be-
come our next generation of vascular surgeons. We must
rekindle an interest in our specialty. Vascular societies
should recognize well-trained vascular surgeons who are
willing to go to medical schools in their area to entice and
counsel the best and brightest medical students to join us in
vascular surgery. For continuity in this endeavor, these
volunteer surgeons should also be available to provide
counsel to interested medical students in their consider-
ation of vascular surgery as a career. Also, we cannot sit idly
and wait for cases to be referred to us. In the past, we
reigned supreme in peripheral vascular care because no one
else had the skills. That is simply no longer the case. The
time is now to aggressively compete against interventional
radiologists and cardiologists and to strive for our indepen-
dence as a specialty. We are few, but we are strong and
determined. We will overcome these and future challenges
because we are a fair and hard-working group of surgeons.
Will Rogers (1879-1935), America’s beloved political
humorist, once observed, “Even if you’re on the right
track, you’ll get run over if you just sit there.” I believe that
we are on the right track, but let us not tarry in the
advancement of our cause—let’s do it!
Thank you.
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